A perspective of smooth muscle contractility through actions of vanadium compounds

Indian Journal of Physiology and Pharmacology

Volumn 43, Issue 3, 1999, Pages 277-295

  Ramasarma, T ^a   Venkataraman, B V ^b  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

Muscle; Smooth muscle; Vanadium

Indexed keywords

4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; ATROPINE; CALCIUM; EGTAZIC ACID; GENISTEIN; INDOMETACIN; ION CHANNEL; MEPYRAMINE; NIFEDIPINE; NITRIC OXIDE; OUABAIN; PERVANADATE; PHENOXYBENZAMINE; PHOSPHATE; PHOSPHOLIPASE D; PRAZOSIN; STAUROSPORINE; VANADIC ACID; VERAPAMIL;

ARTICLE; CALCIUM CELL LEVEL; MEMBRANE DEPOLARIZATION; MUSCLE CONTRACTILITY; OXIDATION REDUCTION REACTION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION;

ANIMALS; ION CHANNELS; MEMBRANE POTENTIALS; MUSCLE CONTRACTION; MUSCLE PROTEINS; MUSCLE, SMOOTH; NA(+)-K(+)-EXCHANGING ATPASE; OXIDATION-REDUCTION; PHOSPHORYLATION; RECEPTORS, CELL SURFACE; VANADIUM COMPOUNDS;

EID: 0032804021     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. rd edn Academic press, New York, 1971; 416-424.
2. Hudson TGF. Vanadium, Toxicology and Biological Significance, Am. Elsevier Science Publication. 1964.
3. Macara IG. Vanadium - an element in search of a role. Trends Biochem Sci 1980; 5: 92-94.
4. Remasarma T, Crane FL. Does vanadium play a role in cellular regulations? Curr Top Cell Regul 1980; 20: 247-301.
5. Nechay R. Mechanism of action of vanadate. Ann Rev Pharmacol Toxicol 1984; 24: 501-524.
6. Domingo JL, Gomez M, Liobet JM, Corbella J, keen CL. Improvement of glucose homeostasis by oral vanadyl or vanadate treatment in diabetic rats is accompanied by negative side effects. Pharmacol Toxicol 1991; 68: 249-253.
7. Vouk V, Vanadium. In Friber L. et al eds. Handbook on the Toxicological of Metals. Elsevier/ North Holland Biochemical Press. 1979; 659-674.
8. Cantley LC Jr, Josephson L, Wanner R, Yanagisawa M, Lachene C, Guidotti G, Vanadate is a potent (Na+, K+)-ATPase. J Biol Chem 1978; 253: 7361-7368.
9. +)-ATPase inhibitors in equine muscle ATP: Vanadate and a dithioerythritol-dependent inhibitors. Biochim Biophys Acta 1978; 551; 202-212.
10. Ramasarma T, Mackellar W, Crane FL. Vanadate stimulated NADH oxidation in plasma membranes. Biochem Biophys Acta 1981; 646: 88-98.
11. Ramasarma T. Vanadium complexes with insulin mimic actions - a second line of protection against diabetes. Ind J Clin Biochem 1996; 11: 92-107.
12. +) ATPase inhibitor, J Biol Chem 1980; 255: 5306-5312.
13. Shechter Y, Karlish SJD. Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl ions. Nature 1980; 284: 556-558.
14. Ozaki H, Urokawa N. Effects of vanadate on mechanical responses and sodium-potassium pump in vascular smooth muscle. Eur J Pharmacol 1980; 68: 339-347.
15. Hackbarth F, Schmitz W, Scholtz H, Wetzel H. Erdmann W, Kraweitz W, Phillip G. Stimulatory effect of vanadate on cyclic AMP levels in cat capillary muscle. Biochem Pharmacol 1980; 29 : 1429-1432.
16. +-pump activity in isolated canine saphenous vein. Fed Proc 1979; 38 : 136.
17. Hudgins PM, Bond GH. Alteration by vanadate of contractility in vascular and intestinal smooth muscle preparations. Pharmacol 1981; 23 : 156-164.
18. Nayler RA, Sparrow MP. Mechanism of vanadate-induced contraction of airways smooth muscle of the guinea-pig. Br J Pharmacol 1983; 80 : 163-172.
19. Shimada T, Shimamura K, Sunano S. Effects of sodium vanadate on various types of vascular smooth muscles. Blood Vessels 1986; 23 : 113-124.
20. Sanchez-Ferrer CF, Marin J, Lluch M, Valverde A, Salaices M. Actions of vanadate on vascular tension and sodium pump activity in cat isolated cerebral and femoral arteries. Br J Pharmacol 1988; 93 : 53-60.
21. Sunano S, Kato S, Moriyama K, Shimamura K. Influences of sodium on the contractile action of vanadate in depolarized vas deferens and ureter of the guinea pig. Arch Int Pharmacodyn Therap 1988; 293 : 196-208.
22. Candura SM, Manzo L, Marraccini P, Coccini T, Tonini M. Investigation into vanadate-induced potentiation of smooth muscle contractility in the rabbit isolated ileum. Life Sci 1993; 54 : 237-244.
23. St. Louis J, Sicotte B, Breton E, Srivastava AK. Contractile effects of vanadate on aorta rings from virgin and pregnant rats. Mol Cell Biochem 1995; 153: 145-150.
24. Ponce-Monter H, Villaneuva T, Ortega BG, Campos MG. Vanadate-induced potentiation of smooth muscle contractility in the rat depolarization uterus. Arch Med Res 1995; 26 : s185-s188.
25. Venkataraman BV, Ravishankar HN, Aparna VS, Kalyani P, Sharada G, Namboodri K, Gabor B, Ramasarma T. Decavanadate possesses α-adrenergic agonist activity and a structural motif common with trans-β form of noradrenaline. Mol Cell Biochem 1997; 169 : 27-36.
26. Azzam Ali, Venkataraman BV. Study of decavanadate on rat tracheal smooth muscle rings. Ind J Aerospace Med 1997; 41 : 107-113.
27. Rapp JP. Aortic responses to vanadate: Independence from (Na,K)-ATPase and comparison of dahl salt-sensitive and salt-resistant rats. Hypertension 1981; 3 : 1168-1172.
28. Garcia AG, Jurkiewicz A, Jurkiewicz NH. Contractile effect of vanadate and other vanadium compounds on the rat vas deferens. Eur J Pharmacol 1981; 70 : 17-23.
29. Ozaki H, Ueda F, Urakawa N. Inhibitory effects of vanadate on the contractile response in vascular smooth muscle. Eur J Pharmacol 1982; 80: 317-322.
30. St. Louis, J., Sicotte, B., Prostaglandin-or endothelium-mediated vasodilation is not involved in the blunted responses of blood vessels to vasoconstrictions in pregnant rats. Am J Obstet Gynecol 1992; 166 : 648-692.
31. 2+-free contraction of uterine smooth muscle of the rat. General Pharmacol 1994; 25 : 1673-1677.
32. Bulbring E, Bradding AF, Jones AW, Tomita T. Smooth muscle: an assessment of current knowledge. Austin, University of Texas Press, 1981.
33. Somlyo AP, Somlyo AV. Vascular smooth muscle. I. Normal structure, pathology, biochemistry, and biophysics. Pharmacol Rev 1968; 20 : 197-272.
34. Cortijo J, Villagrasa V, Marti-Cabrera M, Villar V, Moreau J, Adveneir C, Morcillo EJ, Small RC. The spasmogenic effects of vanadate in human isolated bronchus. Br J Pharmacol 1997; 121 : 1339-1349.
35. Sharada G, Shivaswamy V, Ramasarma T, Kurup CKR. Redistribution of subcellular calcium in rat liver on administration of vanadate. Mol Cell Biochem 1989; 90 : 155-164.
36. Sharada G, Kurup CKR, Ramasarma T. Decavanadate acts like an adrenergic agonist in redistributing protein kinase C activity. FEBS Lett 1990; 267 : 93-95.
37. Sharada G, Shivaswamy V, Ramasarma T, Kurup CKR. Increase in α-glycerophosphate dehydrogenase and other oxidoreductase activities of hepatic mitochondria on administration of vanadate to the rat. Indian J Biochem Biophys 1989; 26 : 277-233.
38. Reinhart PH, Taylor WM, Bygrave FL. Calcium ion fluxes induced by the action of α-adrenergic agonists in perfused rat liver. Biochem J 1982; 208 : 619-630.
39. Squier GJ, Van der Schyf CJ. Oliver DW, Venter PDP. Comparative α-and β-adrenoreceptor activity of 2- and 6-ring chlorinated noradrenaline analogues. Drug Res 1986; 36 : 457-460.
40. Laniyonu A, Saifeddine M, Ahmad S, Hollenberg MD. Regulation of vascular and gastric smooth muscle contractility by pervanadate. Br J pharmacol 1994; 113 : 403-410.
41. 1 smooth muscle. Ann Rev Physiol 1989; 51 : 315-329.
42. Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K, Harada K, Miyamoto S, Nakazawa H, Won K, Sato K. Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev 1997; 49 : 157-230.
43. 2 in biomembranes. Biochim Biophys Acta 1982; 694 : 69-93.
44. Needleman P, Jakschik B, Johnson Jr EM. Sulfhydryl requirement for relaxation of vascular smooth muscle. J Pharmacol Exp Therap 1973; 187 : 324-331.
45. Rabanyi M, Vanhouttee PM. Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. Am J Physiol 1986; 250 : H815-H821.
46. Beny J-L, von der Weid P-Y. Hydrogen peroxide: an endogenous smooth muscle cell hyperpolarizing faactor. Biochem Biophys Res Commun 1991; 176 : 378-384.
47. Ravishankar HN, Aparna VSR, Ramasarma T. Catalase degrades diperoxovanadate and releases oxygen. Arch Biochem Biophys 1995; 321 : 477-484.
48. 45 calcium uptake of the smooth muscle of the guinea-pig taenia coli. J Physiol 1965; 176 : 163-179.
49. Potter JM, Sparrow MP, Simmonds WJ. Increased uptake and efflux of calcium with acetylcholine stimulation in smooth muscle of toad stomach. Aust J exp Biol Med Sci 1970; 48 : 429-443.
50. Sandirasegarane L, Gopalakrishnan V. Vanadate increases cytosolic free calcium in rat aortic smooth muscle cells. Pharmacol Lett 1995; 56 : 167-174.
51. 2+ exchange mechanisms. Am J Physiol 1997; 273 : L320-L330.
52. 45Ca-efflux and sugar transport in adipose tissue and skeletal muscle. Biochim Biophys Acta 1981; 646 : 261-267.
53. 2+ -ATPase and other ATPases. Biochem Biophys Res Commun 1979; 89 : 845-850.
54. Rasmussen H, Takuwa Y, Park S. Protein kinase C in the regulation of smooth muscle contraction. FASEB J 1987; 1 : 177-185.
55. Kobayashi E, Nakano H, Morimoto M, Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1989; 159 : 548-553.
56. Hidaka H, Kobayashi R. Pharmacology of protein kinase inhibitors. Ann Rev Pharmacol Toxicol 1992; 32 : 377-397.
57. Di Salvo J, Steusloff A, Semenchuk L, Satoh S, Kolquist K, Pfitzer G. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem Biophys Res Commun 1993; 190 : 968-974.
58. Murphy RA. What is special about smooth muscle? The significance of covalent crossbridge regulation. FASEB J 1994; 8 : 311-318.
59. Seidel JC. Activation by actin of ATPase activity of chemically modified gizzard myosin without phosphorylation. Biochem Biophys Res Commun 1979; 89 : 958-964.
60. Szymanski PT, Strauss JD, Doerman G, Di Salvo J. Polylysine activates smooth muscle actin-myosin interaction without LC20 phosphorylation. Am J Physiol 1992; 262(31) : C1446-C1455.
61. Fulginiti J, Singer HA, Moreland RS. Phorbolester-induced contractions of swine carotid artery are supported by slowly cycling crossbridges which are not dependent on calcium or myosin light chain phosphorylation. J Vasc Res 1993; 30 : 315-321.
62. Lalli MJ, Obara K, Paul RJ. Vanadate oxidation activates contraction in skinned smooth muscle without myosin light chain phosphorylation. 1997; 272(41) : C278-C288.
63. Kalyani P, Vijaya S, Ramasarma T. Characterization of oxygen free radicals generated during vanadate-stimulated NADH oxidation. Mol Cell Biochem 1992; 111 : 30-40.
64. 2. Arch Biochem Biophys 1990; 279 : 1-7.
65. Brooks HB, Sicilio F. Electron spin resonance kinetic studies of the oxidation of vanadium (IV) by hydrogen peroxide. lnorg Chem 1971; 10 : 2530-2534.
66. Jaswal JS, Tracey AS. Formation and decomposition of peroxovanadium (V) complexes in aqueous solution. Inorg Chem 1991; 30 : 3718-3722.
67. Patole MS, Kurup CKR, Ramasarma T. Reduction of vanadate by a microsomal redox system. Biochem Biophys Res Commun 1986; 141 : 171-175.
68. Howarth OW, Hunt JR. Peroxo-complexes of vanadium (V): A vanadium-51 nuclear magnetic resonance study. JCS Dalton Trans 1979; 1388-1391.
69. 2 in presence of abundant catalase. Biochem Biophys Acta 1998; 1381 : 249-255.
70. Scribner WM, Vepa S, Shamlal R, Ramasarma T, Ravishankar HN, Natarajan V. Tyrosine kinase and calcium dependent regulation of phospholipase D activation by diperoxovanadate in vascular endothelial cells. Mol Cell Biochem 1998; 183 : 113-124.
71. Ravishankar HN, Ramasarma T. Requirement of a diperoxovanadate-derived intermediate for the interdependent oxidation of vanadyl and NADH. Arch Biochem Biophys 1995; 316 : 319-326.
72. Aparna VSR, Ravishankar HN, Ramasarma T. Vanadium catalysis in bromoperoxidation reaction. Arch Biochem Biophys 1996; 334 : 121-134.
73. Ravishankar HN, Chaudhuri MK, Ramasarma T. Oxygen-exchange reactions accompanying oxidation of vanadyl sulfate by diperoxovanadate. Inorg Chem 1994; 33 : 3788-3793.
74. Kodata S, Fantus, IG, Deragon G, Guyda HJ, Posner BI. Peroxide(s) of vanadium: a novel and potent insulin-mimetic agent which activates the insulin receptor kinase. Biochem Biophys Res Commun 1987; 147 : 259-266.
75. D'Onofrio F, Le MQ, Chiasson JL, Srivastava AK. Activation of mitogen activated protein (MAP) kinase by vanadate is independent of insulin receptor autophosphorylation. FEBS Lett 1994; 340 : 269-275.
76. Krady M-M, Malviya AN, Dupont J-L. Pervanadate-triggered MAP kinase activation and cell proliferation are not sensitive to PD 98059. FEBS Lett 1998; 434 : 241-244.
77. Ramasarma T, Sharada G, Vidya S, Kurup CKR. Polyvanadate acts at the level of plasma membranes through α-adrenergic receptor and affects cellular calcium distribution and some oxidative activities. J Biosci 1990; 15 : 205-210.
78. Kalyani P, Ramasarma T. Polyvanadate-stimulated NADH oxidation by plasma membranes-the need for a mixture of deca and meta forms of vanadate. Arch Biochem Biophys 1992; 297 : 244-252.
79. Fantus IG, Kodata S, Deragon G, Foster B, Posner BI. Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase, Biochem 1989; 28 : 8864-8871.
80. Natarajan V, Taher MM, Roehn B, Parinandi NL, Schmid HHO, Kiss Z, Garcia JGN. Activation of endothelial cell phospholipase D by hydrogen peroxide and fatty acid hydroperoxide. J Biol Chem 1993; 268 : 930-937.
81. Kobzik L, Reid MB, Bredt DS, Stamler JS. Nitric oxide in skeletal muscle. Nature (Lond) 1994; 372 : 546-548.
82. Reid MB, Khawii F, Moody M. Reactive oxygen in skeletal muscle III: contractility of unfatigued muscle. J App Physiol 1993; 75 : 1081-1087.
83. Trimm JL, Salama G, Abramson J. Sulfhydryl oxidation induces rapid calcium release from sarcoplasmic reticulum vesicles. J Biol Chem 1986; 261 : 16092-16096.
84. 2 -induced vascular relaxation by endothelium derived relaxating factor. Mol Cell Biochem 1995; 149/150 : 269-270.